PACB News and Press, Pacific Biosciences of California Inc. From 02/16/22

Pacific Biosciences (NASDAQ:PACB) has lost ~10% in the pre-market on Wednesday after several Wall Street analysts slashed their price targets on the life sciences company in reaction to its lower-than-expected earnings for Q4 2021. The company reported $36M in revenue for the quarte...

SINGAPORE and MENLO PARK, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- KK Women’s and Children’s Hospital (KKH) and PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration to leverage PacBio technolo...

Image source: The Motley Fool. Pacific Biosciences of California (NASDAQ: PACB) Q4 2021 Earnings Call Feb 15, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Pacific Biosciences of California (PACB) Q4 2021 Earnings...

Pacific Biosciences of California, Inc. (PACB) Q4 2021 Earnings Conference Call February 15, 2022, 16:30 ET Company Participants Todd Friedman - Director, IR Christian Henry - President, CEO & Director Susan Kim - CFO Mark Van Oene - COO Conference Call Participants Kyle Mikson - Canaccor...

Pacific Biosciences of California press release (NASDAQ:PACB): Q4 Non-GAAP EPS of -$0.30 misses by $0.01. Revenue of $36M in-line. Shares -3.3%. For further details see: Pacific Biosciences of California Non-GAAP EPS of -$0.30 misses by $0.01, revenue of $36M in-line

MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021. Updates since our last earnings release Achieved record fourth quarter revenues of $36.0 million reflecting ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Life sciences equipment manufacturer Bionano Genomics (NASDAQ: BNGO ) was a popular meme stock last year. Consequently, its management raised a massive amount of cash through equity offerings. However, it has failed t...

MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial results on Tuesday, February 15, 2022, at 4:30 pm Eastern Time. The call will be webca...

5 Biotech Stocks For Your Mid-January 2022 Watchlist Biotech stocks have often been a popular theme in the stock market . Even without the catalyst from the ongoing pandemic, the industry is one that many investors keep a close tab on. Now, why is that so? For starters, biotech ...

MENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice President and General Manager for the company’s Americas region. Lara will be responsible...